Immunotec Expanding Throughout Europe With Proven Leadership

According to a recent press release:

What is drawing so many top leaders and influencers to this company’s EU expansion? Europe is heating up for Immunotec, and proven leaders, top earners, and influential voices in wellness are sharing in the excitement. 

At a time when much of direct selling feels noisy, crowded, and increasingly hard to trust, Immunotec is standing out, according to company leadership. 

The company is now accelerating its European expansion with major events in France, Switzerland, and Hungary, building on the kind of growth that has already turned heads in Spain. With more than 40 years of science behind their flagship product and a plan to attract serious leadership early, Immunotec shares that they may have found the formula most companies miss.

Since acquiring Immunotec in 2017, CEO Mauricio Domenzain has helped scale the company to over $200 million by focusing on real leadership, real product differentiation, and real long-term vision. 

A Rare Chance to Become Part of European Expansion

Spain has already become one of the company’s strongest momentum stories in Europe, with rapid market penetration, strong sales growth, and the rise of high-level leadership networks in a relatively short time, leadership shared; now, with France, Switzerland, and Hungary opening up, many leaders see a rare chance to get positioned early with a company that already has proof behind it. 

A major part of that momentum accelerated when industry veteran Mike Potillo stepped in as President, helping attract proven leaders from major companies across the U.S. and Europe. His role in facilitating the MyDailyChoice acquisition at the end of 2025 added even more fuel, opening the door for a wave of recognized leaders, top earners, and large organizations to take a serious look at what Immunotec was building. 

Record-Breaking Success 

After the MyDailyChoice acquisition, leaders did not hesitate, and exciting first-month success stories began surfacing almost immediately.† One of the clearest signals was Josh Zwagil, former CEO of MyDailyChoice, choosing to step into the field himself.

Katie Wiekamp, a social media rock star, is another name that moved quickly, alongside widely recognized industry veterans like Judy Stallings, Chris Robinson, Robert Hollis and Denise Walsh — all of whom have had major success across multiple companies over many years. When names like these move this quickly, people pay attention, the company shared. 

Immunotec has built its reputation on patented nutritional technology designed to support the body’s natural production of glutathione, with 80 patents worldwide, 92 clinical studies, and more than 40 years of continuous research and development behind the company. In the international wellness market, this kind of scientific depth stands out.*

With the company’s reputation, it becomes easier to understand why so many leaders are taking a serious look at what Immunotec is building.

12 Countries In. 8 More on Deck. 

Immunotec is attracting serious attention because it is building around leadership from the start, not just “chasing sales volume.” The company already has leaders reaching major ranks in 12 countries across Europe, with 8 more markets expected to open soon. And the pre-launch momentum is already moving fast. Top earners and recognized leaders like Tibor Odor, Judit Veres, and Sandor Dobi are already in motion, which has attracted a lot of excitement and attention. 

“This is not just another market rollout,”

said Mike Potillo, President of Immunotec.

“Europe is responding to substance. The science is real, the momentum is real, and serious leaders can feel the difference. Spain was just the beginning. What comes next will blow that away.” 

Upcoming European Events

The next phase will come to life through three major European events:

• Budapest, Hungary on May 7, 2026 
• Paris, France on May 9, 2026 
• Montreux, Switzerland on May 10, 2026 

These events are expected to bring together company leadership, rising field leaders, prospects, and wellness entrepreneurs who want to see the story firsthand. 

According to VP Aurelio Fernandez, Europe is responding because the company is bringing the right message to the market at the right time.

“Leaders know when something is real. That is what is happening here. People are seeing significant health results* and earning money,† and when they see that combination, they are excited to get started.” 

In uncertain times, Immunotec is focused on what still matters most. A differentiated product story. A serious business model. Proven leadership at the top. And a Europe expansion that already has proof behind it. 

For leaders, influencers, affiliates, and wellness entrepreneurs looking for something real, these events are where new organizations get built, new stories begin, and new leadership legacies take shape.

Immunotec’s next big wave in Europe is still in its early days. 

Income Disclosure (EU) 

Earnings as an independent consultant with Immunotec depend on individual effort, business activity, and market conditions. 

• There are no guaranteed earnings or income levels. Any references to earnings, success stories, or results (including visual representations) are for illustrative purposes only and do not represent average or expected outcomes. Individual results may vary. 

Any references to earnings, success stories, or results (including visual representations) are for illustrative purposes only and do not represent average or expected outcomes. Individual results may vary. 

• This communication is commercial in nature. 
• It is intended for informational purposes only and does not constitute financial, legal, or medical advice. • Independent consultants act on their own behalf and are not agents or employees of the company.

Transparency Notice 

This material has been prepared in accordance with applicable European consumer protection principles, including requirements to avoid misleading claims, exaggerated income representations, or unsubstantiated product benefits.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

†The examples of results and income shown in this content are only an example. They are designed to give you an idea of what is possible. Individual results may vary. Immunotec does not guarantee that anyone will make a specific amount of money. Success in any business requires leadership, skills, commitment, dedication and will depend on your effort. Immunotec’s Income Disclosure Statement is designed to convey truthful, timely, and complete information about the income that an Immunotec Independent Consultant could earn. For complete information, please review the Immunotec Policies & Procedures and Compensation Plan.